型号：GM-J000540-unknow

应用：肿瘤类型Mammary gland adenomyoepithelioma，诱导方法tamoxifen (for inducing expression from mutant alleles)，发病概率100，参考文献1 Reference: Van Keymeulen A, Nature (2015)

型号：GM-J000539-unknow

应用：肿瘤类型Mammary gland adenocarcinoma - solid，诱导方法，发病概率100，参考文献1 Reference: Ranger JJ, Cancer Res (2009)

型号：GM-J000538-unknow

应用：肿瘤类型Mammary gland adenocarcinoma - solid，诱导方法，发病概率100，参考文献1 Reference: Ranger JJ, Cancer Res (2009)

型号：GM-J000537-unknow

应用：肿瘤类型Mammary gland adenocarcinoma - solid，诱导方法，发病概率100，参考文献1 Reference: Ranger JJ, Cancer Res (2009)

型号：GM-J000536-unknow

应用：肿瘤类型Mammary gland adenocarcinoma，诱导方法，发病概率observed，参考文献1 Reference: Ramovs V, Breast Cancer Res (2019)

型号：GM-J000535-unknow

应用：肿瘤类型Mammary gland adenocarcinoma，诱导方法，发病概率86，参考文献1 Reference: Liu Q, Genes Dev (2000)

型号：GM-J000534-unknow

应用：肿瘤类型Mammary gland adenocarcinoma，诱导方法，发病概率high - 86，参考文献1 Reference: Sinn E, Cell (1987)

型号：GM-J000533-unknow

应用：肿瘤类型Mammary gland adenocarcinoma，诱导方法，发病概率observed - 89，参考文献2 References: Gallego MI, Oncogene (2003)  ⋅  Mikaelian I, Personal Communication (2004)

型号：GM-J000532-unknow

应用：肿瘤类型Mammary gland adenocarcinoma，诱导方法，发病概率89，参考文献1 Reference: Tremblay PJ, Mol Cell Biol (1989)

型号：GM-J000530-unknow

应用：肿瘤类型Mammary gland adenocarcinoma，诱导方法2-difluoromethylornithine (DFMO)，发病概率82 - 92，参考文献1 Reference: Green JE, Cancer Res (2001)